Tarceva – cancer treatment of new generation – has finally appeared on the Russian market. Tarceva is one of five revolutionary pharmaceuticals, which were released in recent five years by world leading Swiss Roche AG.
      
      Said agents are non-toxic and have elective effect on tumor cells, in contrast to traditional chemotherapy and radiation therapy.
      
      Tarceva and other pharmaceuticals are based on genetically modified antibodies, which recognize specific tumor cells and launch mechanisms, eliminating tumors or ceasing their growth. Taking these agents usually extends patient’s life and improves its quality.
      
      Source: Expert Online